N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them

A compound of formula I

• wherein,
• R1 and R4 are independently H, F, Cl, Br, C1-C4-alkyl or C1-C4-alkoxy, wherein the C1-C4-alkyl and C1-C4-alkoxy are independently optionally substituted by 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms;
• R2 and R3 are independently H, F, OH, C1-C3-alkyl or C1-C3-alkoxy, wherein the C1-C3-alkyl and C1-C3-alkoxy are independently optionally substituted by 1, 2, 3, 4, 5, 6 or 7 fluorine atoms;
• R5 is C2-C4-alkenyl or C3-C5-cycloalkyl, wherein the C2-C4-alkenyl and C3-C5-cycloalkyl are independently optionally substituted by 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms;
• and
• R6 and R7 are independently F, Cl, Br, C1-C4-alkyl or C1-C3-alkoxy, wherein the C1-C4-alkyl and C1-C3-alkoxy are independently optionally substituted by 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms,
• or a pharmaceutically acceptable salt or trifluoroacetic acid salt thereof.